PT
Tsantoulis, Petros
Affiliation entities
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Enjeux individuels et collectifs autour de l’évaluation des risques de cancer par l’oncogénétique prédictive | Santé publique | 2030 | 43 | 31 | |||
| Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency : A Diagnostic Challenge | JCEM case reports | 2025 | 7 | 61 | |||
| A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer | Journal of translational medicine | 2025 | 7 | 11 | |||
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine | 2024 | 180 | 0 | |||
| Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors | Cancers | 2024 | 98 | 27 | |||
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | 2024 | 102 | 83 | |||
| Rates of febrile neutropenia and its causes in the real world | Future oncology | 2024 | 25 | 221 | |||
| Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective study | Swiss medical weekly | 2023 | 61 | 51 | |||
| Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer | Swiss medical weekly | 2023 | 95 | 177 | |||
| Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics | International journal of cancer | 2023 | 509 | 86 | |||
| Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma | International journal of molecular sciences | 2023 | 8 | 10 | |||
| The Landscape of Immunotherapy Resistance in NSCLC | Frontiers in oncology | 2022 | 139 | 153 | |||
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | 2022 | 185 | 130 | |||
| Structure-based prediction of BRAF mutation classes using machine-learning approaches | Scientific reports | 2022 | 8 | 7 | |||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | 2022 | 140 | 62 | |||
| Citizens' views on sharing their health data: the role of competence, reliability and pursuing the common good | BMC Medical Ethics | 2021 | 260 | 208 | |||
| Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab | Gynecologic Oncology Reports | 2021 | 259 | 115 | |||
| Precision oncology beyond DNA mutation testing | 2021 | 296 | 7 | ||||
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | 2021 | 333 | 91 | |||
| Automated Detection of Arm-Level Alterations for Individual Cancer Patients in the Clinical Setting | The journal of molecular diagnostics | 2021 | 201 | 248 | |||
| The impact of variant allele frequency in EGFR mutated NSCLCc patients on targeted therapy | Frontiers in Oncology | 2021 | 370 | 189 | |||
| Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis | Nature communications | 2021 | 201 | 61 | |||
| Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer | Cancer Genomics & Proteomics | 2020 | 220 | 133 | |||
| Imaginaires associés aux avancées de la génétique et « médecine du futur » | Áltera | 2020 | 250 | 99 | |||
| Comparison of the clinical utility of two different size next generation sequencing (NGS) gene panels for solid tumours | Molecular Analysis for Precision Oncology (MAP) Virtual Congress 2020 | 2020 | 1 | 0 | |||
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | 2020 | 458 | 296 | |||
| Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation | Gynecologic Oncology Reports | 2020 | 288 | 181 | |||
| Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss | Cancer Biology and Therapy | 2020 | 353 | 162 | |||
| Deep Response to Anti-PD-1 Therapy of Metastatic Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor With CD274/PD-L1 Amplification | JCO precision oncology | 2019 | 1 | 0 | |||
| Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | 2019 | 273 | 822 | |||
| Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors | The Journal of Pathology | 2018 | 889 | 6 | |||
| Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer | Journal of Translational Medicine | 2017 | 478 | 199 | |||
| Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | 2016 | 581 | 232 |
